|
US3773919A
(en)
|
1969-10-23 |
1973-11-20 |
Du Pont |
Polylactide-drug mixtures
|
|
DE2010115A1
(de)
|
1970-03-04 |
1971-09-16 |
Farbenfabriken Bayer Ag, 5090 Leverkusen |
Verfahren zur Herstellung von Mikrogranulaten
|
|
US4389330A
(en)
|
1980-10-06 |
1983-06-21 |
Stolle Research And Development Corporation |
Microencapsulation process
|
|
US4675189A
(en)
|
1980-11-18 |
1987-06-23 |
Syntex (U.S.A.) Inc. |
Microencapsulation of water soluble active polypeptides
|
|
US4474572A
(en)
|
1981-09-29 |
1984-10-02 |
Syntex (U.S.A.) Inc. |
Implanting device and implant magazine
|
|
US4530840A
(en)
|
1982-07-29 |
1985-07-23 |
The Stolle Research And Development Corporation |
Injectable, long-acting microparticle formulation for the delivery of anti-inflammatory agents
|
|
US4758435A
(en)
|
1986-08-11 |
1988-07-19 |
American Cyanamid Company |
Estradiol implant composition and method for preparation
|
|
US5033252A
(en)
|
1987-12-23 |
1991-07-23 |
Entravision, Inc. |
Method of packaging and sterilizing a pharmaceutical product
|
|
US5052558A
(en)
|
1987-12-23 |
1991-10-01 |
Entravision, Inc. |
Packaged pharmaceutical product
|
|
US4900552A
(en)
|
1988-03-30 |
1990-02-13 |
Watson Laboratories, Inc. |
Mucoadhesive buccal dosage forms
|
|
EP0504257A4
(en)
|
1989-11-29 |
1993-03-03 |
Brigham And Women's Hospital |
(ala il-8) 77 as a leukocyte adhesion inhibitor
|
|
US5714167A
(en)
|
1992-06-15 |
1998-02-03 |
Emisphere Technologies, Inc. |
Active agent transport systems
|
|
US6221367B1
(en)
|
1992-06-15 |
2001-04-24 |
Emisphere Technologies, Inc. |
Active agent transport systems
|
|
US5122377A
(en)
*
|
1990-11-19 |
1992-06-16 |
A.H. Robins, Company, Incorporated |
Oral delivery system for veterinary drugs
|
|
EP0551626A1
(en)
|
1991-12-19 |
1993-07-21 |
LEK, tovarna farmacevtskih in kemicnih izdelkov, d.d. |
Thermoreversible gel as a liquid pharmaceutical carrier for a galenic formulation
|
|
US5323907A
(en)
|
1992-06-23 |
1994-06-28 |
Multi-Comp, Inc. |
Child resistant package assembly for dispensing pharmaceutical medications
|
|
US6090925A
(en)
|
1993-03-09 |
2000-07-18 |
Epic Therapeutics, Inc. |
Macromolecular microparticles and methods of production and use
|
|
US5981719A
(en)
|
1993-03-09 |
1999-11-09 |
Epic Therapeutics, Inc. |
Macromolecular microparticles and methods of production and use
|
|
ATE163230T1
(de)
|
1993-03-09 |
1998-02-15 |
Epic Therapeutics Inc |
Makromolekulare mikropartikel und verfahren zu ihrer herstellung
|
|
US5421818A
(en)
|
1993-10-18 |
1995-06-06 |
Inner Ear Medical Delivery Systems, Inc. |
Multi-functional inner ear treatment and diagnostic system
|
|
TW438601B
(en)
|
1994-05-18 |
2001-06-07 |
Janssen Pharmaceutica Nv |
New mucoadhesive emulsion compositions and a process for the preparation thereof
|
|
AU698393B2
(en)
|
1994-06-24 |
1998-10-29 |
Immunex Corporation |
Controlled release polypeptide compositions and methods of treating inflammatory bowel disease
|
|
GB9505032D0
(en)
|
1995-03-13 |
1995-05-03 |
Westminster Lab Ltd |
Improvements in or relating to organic compositions
|
|
IL112834A
(en)
|
1995-03-01 |
2000-12-06 |
Yeda Res & Dev |
Pharmaceutical compositions for controlled release of soluble receptors
|
|
FR2742357B1
(fr)
|
1995-12-19 |
1998-01-09 |
Rhone Poulenc Rorer Sa |
Nanoparticules stabilisees et filtrables dans des conditions steriles
|
|
WO1997031008A1
(en)
|
1996-02-23 |
1997-08-28 |
Industrial Research Limited |
Enzyme detection/assay method and substrates
|
|
IL127872A0
(en)
|
1996-07-19 |
1999-10-28 |
Amgen Inc |
Analogs of cationic proteins
|
|
US5945126A
(en)
|
1997-02-13 |
1999-08-31 |
Oakwood Laboratories L.L.C. |
Continuous microsphere process
|
|
US6045528A
(en)
|
1997-06-13 |
2000-04-04 |
Intraear, Inc. |
Inner ear fluid transfer and diagnostic system
|
|
US5939421A
(en)
|
1997-07-01 |
1999-08-17 |
Signal Pharmaceuticals, Inc. |
Quinazoline analogs and related compounds and methods for treating inflammatory conditions
|
|
IL135258A0
(en)
|
1997-09-26 |
2001-05-20 |
Noven Pharma |
Bioadhesive compositions and methods for topical administration of active agents
|
|
US5985848A
(en)
|
1997-10-14 |
1999-11-16 |
Albert Einstein College Of Medicine Of Yeshiva University |
Inhibitors of nucleoside metabolism
|
|
GB9812426D0
(en)
|
1998-06-10 |
1998-08-05 |
Reckitt & Colmann Prod Ltd |
Improvements in or relating to organic compositions
|
|
US20020009478A1
(en)
|
1998-08-24 |
2002-01-24 |
Douglas Joseph Dobrozsi |
Oral liquid mucoadhesive compositions
|
|
US6319513B1
(en)
|
1998-08-24 |
2001-11-20 |
The Procter & Gamble Company |
Oral liquid mucoadhesive compounds
|
|
US6270802B1
(en)
|
1998-10-28 |
2001-08-07 |
Oakwood Laboratories L.L.C. |
Method and apparatus for formulating microspheres and microcapsules
|
|
CN101062928B
(zh)
|
1999-04-08 |
2010-10-06 |
工业研究有限公司 |
3H,5H-吡咯并[3,2-d]嘧啶-4-酮衍生物的制造方法
|
|
DE60040147D1
(de)
|
1999-05-28 |
2008-10-16 |
Targeted Genetics Corp |
Methoden und zusammensetzungen zur reduktion des tumor-nekrosis-faktor-spiegels (tnf) bei tnf-assoziierten erkrankungen
|
|
SI1194425T1
(sl)
|
1999-06-23 |
2005-12-31 |
Sanofi Aventis Deutschland |
Substituirani benzimidazoli
|
|
US6458387B1
(en)
|
1999-10-18 |
2002-10-01 |
Epic Therapeutics, Inc. |
Sustained release microspheres
|
|
DE19951360A1
(de)
|
1999-10-26 |
2001-05-03 |
Aventis Pharma Gmbh |
Substituierte Indole
|
|
JP4879433B2
(ja)
|
2000-01-13 |
2012-02-22 |
エミスフェアー・テクノロジーズ・インク |
活性剤を送達するための化合物および組成物
|
|
GB0003154D0
(en)
|
2000-02-12 |
2000-04-05 |
Astrazeneca Uk Ltd |
Novel compounds
|
|
WO2001068648A1
(en)
|
2000-03-15 |
2001-09-20 |
Aventis Pharma Deutschland Gmbh |
Substituted beta-carbolines with ikb-kinase inhibiting activity
|
|
ATE446366T1
(de)
|
2000-06-22 |
2009-11-15 |
Genentech Inc |
Agonistische monoklonale antikörper gegen trkc
|
|
US20020013331A1
(en)
|
2000-06-26 |
2002-01-31 |
Williams Robert O. |
Methods and compositions for treating pain of the mucous membrane
|
|
UA81743C2
(uk)
|
2000-08-07 |
2008-02-11 |
Центокор, Инк. |
МОНОКЛОНАЛЬНЕ АНТИТІЛО ЛЮДИНИ, ЩО СПЕЦИФІЧНО ЗВ'ЯЗУЄТЬСЯ З ФАКТОРОМ НЕКРОЗУ ПУХЛИН АЛЬФА (ФНПα), ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ, ЩО ЙОГО МІСТИТЬ, ТА СПОСІБ ЛІКУВАННЯ РЕВМАТОЇДНОГО АРТРИТУ
|
|
AU2001284564A1
(en)
|
2000-08-29 |
2002-03-13 |
Albert Einstein College Of Medicine Of Yeshiva University |
Nucleoside metabolism inhibitors
|
|
JP4272338B2
(ja)
|
2000-09-22 |
2009-06-03 |
バイエル アクチェンゲゼルシャフト |
ピリジン誘導体
|
|
HUP0303696A3
(en)
*
|
2000-09-25 |
2005-05-30 |
Bayer Healthcare Llc Tarrytown |
Otic microbial combinations for treatment of animals with ruptured tympanic membrane
|
|
EP1324759A4
(en)
|
2000-10-12 |
2004-05-12 |
Smithkline Beecham Corp |
NF - G (K) B INHIBITORS
|
|
WO2002030423A1
(en)
|
2000-10-12 |
2002-04-18 |
Smithkline Beecham Corporation |
NF-λB INHIBITORS
|
|
CA2427284A1
(en)
|
2000-10-26 |
2002-05-30 |
Tularik Inc. |
Antiinflammation agents
|
|
JP2002193938A
(ja)
|
2000-12-01 |
2002-07-10 |
Bayer Ag |
４−アリールピリジン誘導体
|
|
US7122544B2
(en)
|
2000-12-06 |
2006-10-17 |
Signal Pharmaceuticals, Llc |
Anilinopyrimidine derivatives as IKK inhibitors and compositions and methods related thereto
|
|
AU2002246956B2
(en)
|
2001-01-04 |
2006-11-02 |
Albert Einstein College Of Medicine Of Yeshiva University |
Inhibitors of ADP-ribosyl transferases, cyclases, and hydrolases, and uses thereof
|
|
SE0100158D0
(sv)
|
2001-01-19 |
2001-01-19 |
Synphora Ab |
Novel method and composition for local treatment of Meniere´s disease and tinnitus
|
|
MXPA03006817A
(es)
|
2001-02-01 |
2003-11-13 |
Bristol Myers Squibb Co |
Metodo de tratamiento de enfermedades inflamatorias e inmunes usando inhibidores de la ikb cinasa (ikk).
|
|
FR2823441B1
(fr)
*
|
2001-04-12 |
2004-09-10 |
Thea Lab |
Composition pharmaceutique a base de macrolides pour application locale en ophtalmologie et son procede de preparation
|
|
US20030045515A1
(en)
|
2001-05-24 |
2003-03-06 |
Lise Binderup |
Combination medicament for treatment of neoplastic diseases
|
|
WO2002094265A1
(en)
|
2001-05-24 |
2002-11-28 |
Leo Pharma A/S |
A method of modulating nf-$g(k)b activity
|
|
SE0102617D0
(sv)
|
2001-07-25 |
2001-07-25 |
Astrazeneca Ab |
Novel compounds
|
|
ATE363473T1
(de)
|
2001-09-19 |
2007-06-15 |
Pharmacia Corp |
Substituierte pyrazoloverbindungen zur behandlung von entzündungen
|
|
MXPA04002667A
(es)
|
2001-09-19 |
2004-06-18 |
Pharmacia Corp |
Compuestos de pirazolilo sustituido para el tratamiento de la inflacion.
|
|
DE60229975D1
(de)
|
2001-10-04 |
2009-01-02 |
Smithkline Beecham Corp |
Nf-kb-inhibitoren
|
|
CN1310937C
(zh)
|
2001-11-21 |
2007-04-18 |
犹太大学阿尔伯特爱因斯坦医学院 |
Sir2产物及活性
|
|
MXPA04005427A
(es)
|
2001-12-10 |
2005-04-19 |
Amgen Inc |
Ligandos de receptor vainilloide y su uso en tratamientos.
|
|
CN1627944A
(zh)
|
2002-01-17 |
2005-06-15 |
神经能质公司 |
取代的喹唑啉－4－基胺类似物作为辣椒辣素调节剂
|
|
JP2003277383A
(ja)
|
2002-03-14 |
2003-10-02 |
Bayer Ag |
光学活性ピリジン誘導体およびそれを含む医薬
|
|
US7098334B2
(en)
|
2002-03-25 |
2006-08-29 |
Industrial Research Limited |
4-amino-5H-pyrrolo[3,2-d]pyrimidine inhibitors of nucleoside phosphorylases and nucleosidases
|
|
WO2003099284A1
(en)
|
2002-05-22 |
2003-12-04 |
Amgen Inc. |
Amino-pyridine, -pyridine and pyridazine derivatives for use as vanilloid receptor ligands for the treatment of pain
|
|
US7022680B2
(en)
|
2002-05-30 |
2006-04-04 |
Albert Einstein College Of Medicine Of Yeshiva University |
Inhibitors of ADP-ribosyl transferases, cyclases, and hydrolases
|
|
FR2841243B1
(fr)
*
|
2002-06-19 |
2004-08-20 |
Servier Lab |
Nouveaux derives de 3-(4-oxo-4h-chromen-2yl)-(1h)-quinolein- 4-ones, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
|
|
BR0313255A
(pt)
|
2002-08-08 |
2005-07-12 |
Amgen Inc |
Composto, composição farmacêutica, uso de um composto e métodos de fabricar um medicamento e de preparar um composto
|
|
US7220431B2
(en)
*
|
2002-11-27 |
2007-05-22 |
Regents Of The University Of Minnesota |
Methods and compositions for applying pharmacologic agents to the ear
|
|
US7582635B2
(en)
|
2002-12-24 |
2009-09-01 |
Purdue Pharma, L.P. |
Therapeutic agents useful for treating pain
|
|
US20040185047A1
(en)
|
2003-03-21 |
2004-09-23 |
Jill Giles-Komar |
Anti- TNF antibodies, compositions, methods and uses
|
|
ATE457308T1
(de)
|
2003-04-21 |
2010-02-15 |
Lilly Co Eli |
Substituierte benzopyrane als selektive antagonisten am östrogenrezeptor-beta
|
|
US20040247575A1
(en)
|
2003-06-03 |
2004-12-09 |
Caplice Noel M. |
Smooth muscle progenitor cells
|
|
US7329664B2
(en)
|
2003-07-16 |
2008-02-12 |
Neurogen Corporation |
Substituted (7-pyridyl-4-phenylamino-quinazolin-2-yl)-methanol analogues
|
|
AU2004259357B2
(en)
|
2003-07-24 |
2010-02-18 |
Euro-Celtique S.A. |
Piperidine compounds and pharmaceutical compositions containing them
|
|
AU2004278382B2
(en)
|
2003-09-30 |
2008-09-18 |
Amgen Inc. |
Vanilloid receptor ligands and their use in treatments
|
|
SG166768A1
(en)
|
2003-12-23 |
2010-12-29 |
Rinat Neuroscience Corp |
Agonist anti-trkc antibodies and methods using same
|
|
US7312330B2
(en)
|
2003-12-24 |
2007-12-25 |
Renovis, Inc. |
Bicycloheteroarylamine compounds as ion channel ligands and uses thereof
|
|
TW200530235A
(en)
|
2003-12-24 |
2005-09-16 |
Renovis Inc |
Bicycloheteroarylamine compounds as ion channel ligands and uses thereof
|
|
US20060063802A1
(en)
|
2004-03-29 |
2006-03-23 |
Matthieu Guitton |
Methods for the treatment of tinnitus induced by cochlear excitotoxicity
|
|
US8268866B2
(en)
|
2004-03-29 |
2012-09-18 |
Matthieu Guitton |
Methods for the treatment of tinnitus induced by cochlear excitotoxicity
|
|
MXPA06012870A
(es)
|
2004-05-12 |
2007-02-15 |
Aventis Pharma Inc |
Acido 2-{[2-(2- metilaminopirimidin -4-il)-1h- indol-5 -carbonil]amino}-3 -(fenilpiridin -2-ilamino) propionico sustancialmente puro como inhibidor de la cinasa ikb.
|
|
US8870826B2
(en)
|
2004-05-24 |
2014-10-28 |
Auris Medical Llc |
Combined otic aspirator and medication dispenser
|
|
US8498681B2
(en)
|
2004-10-05 |
2013-07-30 |
Tomophase Corporation |
Cross-sectional mapping of spectral absorbance features
|
|
US20060105967A1
(en)
|
2004-11-18 |
2006-05-18 |
Advanced Gene Technology, Corp. |
Flavone derivatives as TNFalpha inhibitors or antagonists
|
|
CA2591296A1
(en)
|
2004-12-09 |
2006-06-15 |
Bayer Healthcare Ag |
Stabilisation of glucocorticoid esters with acids
|
|
UA92731C2
(ru)
*
|
2004-12-09 |
2010-12-10 |
Баер Энимал Хелс Гмбх |
Лекарственное средство для гигиеничной обработки уха
|
|
DE102005055385A1
(de)
*
|
2004-12-09 |
2006-06-14 |
Bayer Healthcare Ag |
Arzneimittel zur hygienischen Applikation im Ohr
|
|
AR053114A1
(es)
|
2005-01-12 |
2007-04-25 |
Aventis Pharma Inc |
Sal monopotasica del acido 2-{[2-(-2-metilamino-pirimidin-4-il)-1h-indol-5-carbonil]-amino}-3-(fenilpiridin-2-il-amino)-propionico,inhibidora de ikk-2 quinasa
|
|
JP2008527002A
(ja)
|
2005-01-13 |
2008-07-24 |
サートリス ファーマシューティカルズ， インコーポレイテッド |
神経変性障害および血液凝固障害を予防および処置するための新規組成物
|
|
EP1836203A2
(en)
|
2005-01-14 |
2007-09-26 |
Neurogen Corporation |
Heteroaryl substituted quinolin-4-ylamine analogues
|
|
AU2006208042A1
(en)
|
2005-01-25 |
2006-08-03 |
Neurogen Corporation |
Substituted pyridazinyl-and pyrimidinyl-quinolin-4-ylamine analogues
|
|
US20060221197A1
(en)
|
2005-03-30 |
2006-10-05 |
Jung Edward K |
Image transformation estimator of an imaging device
|
|
US7576099B2
(en)
|
2005-02-28 |
2009-08-18 |
Renovis, Inc. |
Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same
|
|
CN101163481A
(zh)
*
|
2005-03-04 |
2008-04-16 |
纽罗赛斯特克公司 |
改进的加环利定制剂
|
|
ES2331153T3
(es)
|
2005-03-10 |
2009-12-22 |
Pfizer Inc. |
Compuestos de n-sulfonilaminofeniletil-2-fenoxiacetamida sustituidos.
|
|
CA2601468A1
(en)
|
2005-03-14 |
2006-09-21 |
Renovis, Inc. |
Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same
|
|
JP4521463B2
(ja)
|
2005-03-17 |
2010-08-11 |
ファイザー株式会社 |
疼痛の治療に有用なｎ−（ｎ−スルホニルアミノメチル）シクロプロパンカルボキサミド誘導体
|
|
CA2610354C
(en)
|
2005-05-31 |
2011-03-29 |
Pfizer Inc. |
Substituted aryloxy-n-bicyclomethyl acetamide compounds as vr1 antagonists
|
|
US7785834B2
(en)
|
2005-11-10 |
2010-08-31 |
Ercole Biotech, Inc. |
Soluble TNF receptors and their use in treatment of disease
|
|
WO2007091970A1
(en)
|
2006-02-06 |
2007-08-16 |
Synphora Ab |
Novel method and compositions for treatment of tinnitus
|
|
EP2005687B1
(en)
|
2006-03-24 |
2017-06-28 |
LG Electronics Inc. |
A method and structure of configuring preamble to support transmission of data symbol in a wireless communication system
|
|
US7744746B2
(en)
|
2006-03-31 |
2010-06-29 |
Exxonmobil Research And Engineering Company |
FCC catalyst stripper configuration
|
|
EP2066302A2
(en)
*
|
2006-09-26 |
2009-06-10 |
Taro Pharmaceuticals North America, Inc. |
Stabilizing compositions for antibiotics and methods of use
|
|
US8377898B2
(en)
|
2006-10-12 |
2013-02-19 |
Idera Pharmaceuticals, Inc. |
Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor based immune response
|
|
CA2672750A1
(en)
|
2006-12-20 |
2008-07-03 |
Rinat Neuroscience Corporation |
Trkb agonists for treating autoimmune disorders
|
|
EP2732819B1
(en)
|
2008-02-07 |
2019-10-16 |
Massachusetts Eye & Ear Infirmary |
Compounds that enhance Atoh-1 expression
|
|
KR20130097813A
(ko)
|
2008-04-21 |
2013-09-03 |
오토노미, 인코포레이티드 |
귀 질환 및 병태를 치료하기 위한 귀 조제물
|
|
US9200080B2
(en)
|
2010-09-03 |
2015-12-01 |
Horacio Uri Saragovi |
Agonistic antibodies to TrkC receptors and uses thereof
|
|
US9125894B2
(en)
|
2010-10-06 |
2015-09-08 |
Massachusetts Eye & Ear Infirmary |
Methods for promoting reinnervation of auditory hair cells
|
|
EP2667881A4
(en)
|
2011-01-24 |
2015-04-22 |
Univ Leland Stanford Junior |
METHOD FOR IN VITRO GENERATION OF INTERNAL CELLS
|
|
US20140234227A1
(en)
*
|
2011-10-10 |
2014-08-21 |
Otic Pharma Ltd. |
Foam formulations
|
|
DE202012100195U1
(de)
|
2012-01-19 |
2012-03-01 |
Nordmark Arzneimittel Gmbh & Co. Kg |
Neue Verwendung einer pharmazeutischen Zusammensetzung, enthaltend Ancrod
|
|
JP2015511242A
(ja)
|
2012-02-23 |
2015-04-16 |
インセルム（インスティチュート ナショナル デ ラ サンテ エ デ ラリシェルシェ メディカル） |
病変性前庭障害の治療に使用するカルシニューリン阻害剤
|
|
WO2013173803A2
(en)
*
|
2012-05-17 |
2013-11-21 |
Michael Spector |
Formulations of amoxicillin and clavulanate potassium and methods for using same
|
|
EP2854829A1
(en)
|
2012-05-30 |
2015-04-08 |
Sensorion |
Methods for treating vestibulotoxicity
|
|
EP3378476A1
(en)
|
2012-06-08 |
2018-09-26 |
Sensorion |
H4 receptor inhibitors for treating tinnitus
|
|
CA2883896C
(en)
|
2012-09-07 |
2023-03-07 |
Massachusetts Eye & Ear Infirmary |
Treating hearing loss
|
|
EP2853533A1
(de)
|
2013-09-29 |
2015-04-01 |
Audiocure Pharma GmbH |
6-Fluor-9-methyl-ß-carbolin
|
|
WO2015168149A2
(en)
|
2014-04-28 |
2015-11-05 |
Massachusetts Eye & Ear Infirmary |
Sensorineural hair cell differentiation
|
|
US20170216439A1
(en)
*
|
2014-07-29 |
2017-08-03 |
Otonomy, Inc. |
Otic formulations for the treatment of ceruminosis
|
|
FR3024361B1
(fr)
|
2014-07-30 |
2017-11-24 |
Affichem |
Utilisation de derives de sterols pour traitement de la perte auditive neurosensorielle et composition correspondante
|
|
EP2982382A1
(en)
|
2014-08-04 |
2016-02-10 |
Sensorion |
Compounds for preventing ototoxicity
|
|
WO2016022776A2
(en)
|
2014-08-06 |
2016-02-11 |
Massachusetts Eye And Ear Infirmary |
Increasing atoh1 life to drive sensorineural hair cell differentiantion
|
|
DE202015100655U1
(de)
*
|
2015-02-03 |
2016-02-04 |
Bio.Lo.Ga. S.R.L. |
Pharmazeutische Zusammensetzung zur topischen Anwendung im Gehörgang
|
|
WO2016128438A1
(en)
|
2015-02-11 |
2016-08-18 |
Support-Venture Gmbh |
Method of preventing or treating hearing loss
|
|
TWI625332B
(zh)
|
2015-07-07 |
2018-06-01 |
美國禮來大藥廠 |
刻痕（ｎｏｔｃｈ）路徑傳訊抑制化合物
|